# Effect of Mosapride on Gut Transit in Patients With Chronic Constipation or Constipated Irritable Bowel Syndrome and Healthy Subjects

> **NCT02433847** · PHASE4 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Constipated Irritable Bowel Syndrome
- Chronic Constipation
- Healthy

## Interventions

- **DRUG:** Mosapride

## Key facts

- **NCT ID:** NCT02433847
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2016-04
- **Final completion:** 2016-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2015-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02433847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02433847, "Effect of Mosapride on Gut Transit in Patients With Chronic Constipation or Constipated Irritable Bowel Syndrome and Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02433847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*